While the extent of protein expression of DYRK1A, which has recently been identified to be a negative regulator of cardiac hypertrophy [15], was not changed in our transgenic model, we observed a concomitant upregulation of DYRK2 in animals overexpressing eIF2Bε. The gene discussed is DYRK1A; the disease is cardiac hypertrophy.